These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30363880)

  • 1. Current Concepts in the Treatment of Multiple System Atrophy.
    Perez-Lloret S; Flabeau O; Fernagut PO; Pavy-Le Traon A; Rey MV; Foubert-Samier A; Tison F; Rascol O; Meissner WG
    Mov Disord Clin Pract; 2015 Mar; 2(1):6-16. PubMed ID: 30363880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple system atrophy: current and future approaches to management.
    Flabeau O; Meissner WG; Tison F
    Ther Adv Neurol Disord; 2010 Jul; 3(4):249-63. PubMed ID: 21179616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible multiple system atrophy with predominant parkinsonism in a patient with chronic schizophrenia: a case report.
    Komatsu H; Kato M; Kinpara T; Ono T; Kakuto Y
    BMC Psychiatry; 2018 May; 18(1):141. PubMed ID: 29783976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple System Atrophy - Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder.
    Ortiz JF; Betté S; Tambo W; Tao F; Cozar JC; Isaacson S
    Cureus; 2020 Sep; 12(9):e10741. PubMed ID: 33173654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple system atrophy.
    Wenning GK; Geser F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S31-8. PubMed ID: 12773886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expanding concept of clinical conditions and symptoms in multiple system atrophy].
    Watanabe H; Riku Y; Nakamura T; Hara K; Ito M; Hirayama M; Yoshida M; Katsuno M; Sobue G
    Rinsho Shinkeigaku; 2016 Jul; 56(7):457-64. PubMed ID: 27356737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.
    Koga S; Dickson DW
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the cerebellar subtype of multiple system atrophy.
    Ciolli L; Krismer F; Nicoletti F; Wenning GK
    Cerebellum Ataxias; 2014; 1():14. PubMed ID: 26331038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy: an update.
    Wenning GK; Geser F; Stampfer-Kountchev M; Tison F
    Mov Disord; 2003 Sep; 18 Suppl 6():S34-42. PubMed ID: 14502654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.
    Poewe W; Mahlknecht P; Krismer F
    Mov Disord; 2015 Sep; 30(11):1528-38. PubMed ID: 26227071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple system atrophy of the cerebellar type: clinical state of the art.
    Lin DJ; Hermann KL; Schmahmann JD
    Mov Disord; 2014 Mar; 29(3):294-304. PubMed ID: 24615754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple system atrophy.
    Wenning GK; Seppi K; Scherfler C; Stefanova N; Puschban Z
    Semin Neurol; 2001; 21(1):33-40. PubMed ID: 11346023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.
    Lin DJ; Hermann KL; Schmahmann JD
    Cerebellum; 2016 Dec; 15(6):663-679. PubMed ID: 26467153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple system atrophy: pathophysiology and management.
    Wenning GK; Braune S
    CNS Drugs; 2001; 15(11):839-52. PubMed ID: 11700149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple system atrophy.
    Wenning GK; Krismer F
    Handb Clin Neurol; 2013; 117():229-41. PubMed ID: 24095129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple system atrophy: clinical presentation and diagnosis.
    Austin MT; Davis TL; Robertson D; Charles PD
    Tenn Med; 1999 Feb; 92(2):55-7. PubMed ID: 9932532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.
    Pérez-Lloret S; Quarracino C; Otero-Losada M; Rascol O
    Expert Opin Pharmacother; 2019 Apr; 20(6):635-645. PubMed ID: 30730771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.